Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Song

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Dermatology|December 11, 2014
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitisYoko Murata, Michael Song, Hisayuki Kikuchi, et al.
Journal of Dermatological Science|July 12, 2011
Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)Tsen-Fang Tsai, Ji-Chen Ho, Michael Song, et al.
Journal of Personalized Medicine|February 25, 2023
Identification of the Magna Radicular Artery Entry Foramen and Adamkiewicz System: Patient Selection for Open versus Full-Endoscopic Thoracic Spinal Decompression SurgeryRoth Antonio Vargas, Eduardo Miquelino De Olinveira, Marco Moscatelli, et al.
Digestive Diseases and Sciences|September 25, 2024
Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort StudyVenkata Sai Jayakrishna Jasty, Esteban Urias, Kai Le Ashley Tiong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.
Journal of Personalized Medicine|March 29, 2023
Clinical Consequences of Incidental Durotomy during Full-Endoscopic Lumbar Decompression Surgery in Relation to Intraoperative Epidural Pressure MeasurementsRoth A A Vargas, Marco Moscatelli, Marcos Vaz de Lima, et al.
BMC Complementary and Alternative Medicine|September 4, 2017
Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasisHui-Man Cheng, Yang-Chang Wu, Qingmin Wang, et al.
Journal of the American Academy of Dermatology|December 7, 2019
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trialsKristian Reich, Christopher E M Griffiths, Kenneth B Gordon, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 DiabetesChutian Shu, Hu Ge, Michael Song, et al.
Gastroenterology|March 6, 2026
Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized TrialJean-Frédéric Colombel, Damian Garcia Olmo, Szu-Ta Chen, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Dermatology|December 11, 2014
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitisYoko Murata, Michael Song, Hisayuki Kikuchi, et al.
Journal of Dermatological Science|July 12, 2011
Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)Tsen-Fang Tsai, Ji-Chen Ho, Michael Song, et al.
Journal of Personalized Medicine|February 25, 2023
Identification of the Magna Radicular Artery Entry Foramen and Adamkiewicz System: Patient Selection for Open versus Full-Endoscopic Thoracic Spinal Decompression SurgeryRoth Antonio Vargas, Eduardo Miquelino De Olinveira, Marco Moscatelli, et al.
Digestive Diseases and Sciences|September 25, 2024
Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort StudyVenkata Sai Jayakrishna Jasty, Esteban Urias, Kai Le Ashley Tiong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.
Journal of Personalized Medicine|March 29, 2023
Clinical Consequences of Incidental Durotomy during Full-Endoscopic Lumbar Decompression Surgery in Relation to Intraoperative Epidural Pressure MeasurementsRoth A A Vargas, Marco Moscatelli, Marcos Vaz de Lima, et al.
BMC Complementary and Alternative Medicine|September 4, 2017
Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasisHui-Man Cheng, Yang-Chang Wu, Qingmin Wang, et al.
Journal of the American Academy of Dermatology|December 7, 2019
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trialsKristian Reich, Christopher E M Griffiths, Kenneth B Gordon, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 DiabetesChutian Shu, Hu Ge, Michael Song, et al.
Gastroenterology|March 6, 2026
Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized TrialJean-Frédéric Colombel, Damian Garcia Olmo, Szu-Ta Chen, et al.
Pageof 7